Clinical Trial Update: MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MRI and PET/FMISO imaging to assess tumor hypoxia in patients with newly diagnosed glioblastoma multiforme; trial completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2019-04-08